Brian Mcdonough Purchases 10,000 Shares of Quotient Ltd (QTNT) Stock

Quotient Ltd (NASDAQ:QTNT) Director Brian Mcdonough purchased 10,000 shares of Quotient stock in a transaction that occurred on Thursday, February 8th. The shares were acquired at an average price of $3.87 per share, for a total transaction of $38,700.00. Following the acquisition, the director now owns 47,747 shares in the company, valued at $184,780.89. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Shares of Quotient Ltd (NASDAQ QTNT) traded down $0.12 during trading hours on Monday, reaching $3.48. The company had a trading volume of 231,689 shares, compared to its average volume of 613,848. Quotient Ltd has a 52 week low of $2.78 and a 52 week high of $7.74. The stock has a market cap of $164.12, a P/E ratio of -1.52 and a beta of 0.74. The company has a debt-to-equity ratio of 22.54, a quick ratio of 1.65 and a current ratio of 2.34.

A number of large investors have recently made changes to their positions in the stock. Wells Fargo & Company MN increased its holdings in Quotient by 1,722.9% during the 4th quarter. Wells Fargo & Company MN now owns 33,961 shares of the company’s stock valued at $168,000 after purchasing an additional 32,098 shares during the period. Highbridge Capital Management LLC increased its holdings in Quotient by 53.7% during the 3rd quarter. Highbridge Capital Management LLC now owns 307,308 shares of the company’s stock valued at $1,515,000 after purchasing an additional 107,308 shares during the period. Perceptive Advisors LLC grew its holdings in shares of Quotient by 0.3% during the 3rd quarter. Perceptive Advisors LLC now owns 3,726,986 shares of the company’s stock worth $18,374,000 after acquiring an additional 12,500 shares during the period. Ameriprise Financial Inc. grew its holdings in shares of Quotient by 5.0% during the 3rd quarter. Ameriprise Financial Inc. now owns 1,921,259 shares of the company’s stock worth $9,472,000 after acquiring an additional 91,364 shares during the period. Finally, California State Teachers Retirement System purchased a new position in shares of Quotient during the 2nd quarter worth approximately $349,000. Institutional investors own 47.33% of the company’s stock.

QTNT has been the topic of a number of research analyst reports. Jefferies Group reduced their price target on Quotient from $15.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, November 1st. BTIG Research restated a “buy” rating and set a $12.00 price target on shares of Quotient in a report on Wednesday, November 1st. Finally, Zacks Investment Research downgraded Quotient from a “hold” rating to a “sell” rating in a report on Thursday, November 2nd.

TRADEMARK VIOLATION NOTICE: This piece of content was posted by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/02/12/brian-mcdonough-purchases-10000-shares-of-quotient-ltd-qtnt-stock.html.

About Quotient

Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.

Insider Buying and Selling by Quarter for Quotient (NASDAQ:QTNT)

Receive News & Ratings for Quotient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply